ArticleJACC. Advances2026

Development of a Predictive Tool in Patients With High Pretest Probability for Transthyretin Amyloid Cardiomyopathy.

Jocelyn Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.